<code id='4D5EDDA1C2'></code><style id='4D5EDDA1C2'></style>
    • <acronym id='4D5EDDA1C2'></acronym>
      <center id='4D5EDDA1C2'><center id='4D5EDDA1C2'><tfoot id='4D5EDDA1C2'></tfoot></center><abbr id='4D5EDDA1C2'><dir id='4D5EDDA1C2'><tfoot id='4D5EDDA1C2'></tfoot><noframes id='4D5EDDA1C2'>

    • <optgroup id='4D5EDDA1C2'><strike id='4D5EDDA1C2'><sup id='4D5EDDA1C2'></sup></strike><code id='4D5EDDA1C2'></code></optgroup>
        1. <b id='4D5EDDA1C2'><label id='4D5EDDA1C2'><select id='4D5EDDA1C2'><dt id='4D5EDDA1C2'><span id='4D5EDDA1C2'></span></dt></select></label></b><u id='4D5EDDA1C2'></u>
          <i id='4D5EDDA1C2'><strike id='4D5EDDA1C2'><tt id='4D5EDDA1C2'><pre id='4D5EDDA1C2'></pre></tt></strike></i>

          Home / comprehensive / hotspot

          hotspot


          hotspot

          author:Wikipedia    Page View:6
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In